Literature DB >> 20875225

Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.

D S Kern1, K N Maclean, H Jiang, E Y Synder, J R Sladek, K B Bjugstad.   

Abstract

Tau accumulation, in the form of neurofibrillary tangles (NFT), is an early neuropathological characteristic of Alzheimer's disease (AD) and early onset AD frequently seen in Down syndrome (DS). We investigated the presence of tau accumulation in the brains of aging DS mice using the Ts65Dn mouse model. All aged mice appeared to have substantial clusters of extracellular granules that were positive for tau and reelin, but not for amyloid-β or APP. These clusters were found primarily in CA1 of the hippocampus. In addition, the aged trisomic DS mice had a significantly greater accumulation of extracellular tau/reelin granular deposits compared to disomic littermates. These granules were similar to those described by others who also found extracellular proteinous granules in the brains of non-DS mice engineered to model aging and/or AD. When neural stem cells (NSC) were implanted unilaterally into the hippocampus of the Ts65Dn mice, the tau/reelin-positive granules were significantly reduced in both trisomic and disomic mice. Our findings indicate that changes in tau/reelin-positive granules could be used as an index for neuropathological assessment in aging DS and AD. Furthermore, changes in granule density could be used to test the efficacy of novel treatments, such as NSC implantation. Lastly, it is speculated that the unique abilities of NSC to migrate and express growth factors might be a contributing factor to reducing tau/reelin accumulation in aging DS and AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875225     DOI: 10.3727/096368910X528085

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  16 in total

Review 1.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

2.  Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury.

Authors:  Yuji Kaneko; Naoki Tajiri; Seongjin Yu; Takuro Hayashi; Christine E Stahl; Eunkyung Bae; Humberto Mestre; Nicholas Franzese; Antonio Rodrigues; Maria C Rodrigues; Hiroto Ishikawa; Kazutaka Shinozuka; Whitney Hethorn; Nathan Weinbren; Loren E Glover; Jun Tan; Anilkumar Harapanahalli Achyuta; Harry van Loveren; Paul R Sanberg; Sundaram Shivsankar; Cesar V Borlongan
Journal:  Cell Med       Date:  2012

3.  Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat.

Authors:  T A Womble; S Green; M Shahaduzzaman; J Grieco; P R Sanberg; K R Pennypacker; A E Willing
Journal:  Mol Cell Neurosci       Date:  2014-01-25       Impact factor: 4.314

Review 4.  Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.

Authors:  Ghanshyam Upadhyay; Sharmila Shankar; Rakesh K Srivastava
Journal:  Mol Neurobiol       Date:  2014-09-23       Impact factor: 5.590

5.  Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican.

Authors:  Matthew D Howell; Paul E Gottschall
Journal:  ASN Neuro       Date:  2012-02-08       Impact factor: 4.146

6.  The use of mouse models for understanding the biology of down syndrome and aging.

Authors:  Guido N Vacano; Nathan Duval; David Patterson
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-23

7.  Age-related neurodegeneration and memory loss in down syndrome.

Authors:  Jason P Lockrow; Ashley M Fortress; Ann-Charlotte E Granholm
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-20

8.  Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndrome.

Authors:  Angela L Rachubinski; Shannon K Crowley; John R Sladek; Kenneth N Maclean; Kimberly B Bjugstad
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

9.  Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.

Authors:  Il-Shin Lee; Kwangsoo Jung; Il-Sun Kim; Haejin Lee; Miri Kim; Seokhwan Yun; Kyujin Hwang; Jeong Eun Shin; Kook In Park
Journal:  Mol Neurodegener       Date:  2015-08-21       Impact factor: 14.195

Review 10.  Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.

Authors:  Kristine Freude; Carlota Pires; Poul Hyttel; Vanessa Jane Hall
Journal:  J Clin Med       Date:  2014-12-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.